Cargando…
Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome
The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the Center for International Blood and Marrow Transplant Research (CIBMTR) we compared the outcomes of patients who had EMD of AML at any time prio...
Autores principales: | Goyal, Sagun D., Zhang, Mei-Jie, Wang, Hai-Lin, Akpek, Görgün, Copelan, Edward A., Freytes, César, Gale, Robert Peter, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Ritchie, David S., Saber, Wael, Savani, Bipin N., Seber, Adriana, Shea, Thomas C., Tallman, Martin S., Wirk, Baldeep, Bunjes, Donald W., Devine, Steven M., de Lima, Marcos, Weisdorf, Daniel J., Uy, Geoffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527880/ https://www.ncbi.nlm.nih.gov/pubmed/25915806 http://dx.doi.org/10.1038/bmt.2015.82 |
Ejemplares similares
-
Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time
por: Kumar, Shaji K, et al.
Publicado: (2017) -
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma
por: Klyuchnikov, Evgeny, et al.
Publicado: (2015) -
ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR
por: Bachanova, Veronika, et al.
Publicado: (2014) -
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis
por: Mahindra, Anuj, et al.
Publicado: (2017) -
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated
por: Nikiforow, Sarah, et al.
Publicado: (2018)